Table 1.
Demographic and clinical characteristics of patients in groups 1, 2, and 3
| N of patients | Group 1 | Group 2 | Group 3 | p value |
|---|---|---|---|---|
| 152 | 57 | 24 | ||
| Age mean ± SD | 32.84 ± 7.52 | 35.12 ± 7.64 | 33,71 ± 4.46 | 0.1421 |
| BMI mean ± SD kg/m2 | 24,72 ± 5.59 | 24,77 ± 5.68 | 25,78 ± 6.61 | 0.9903 |
| Dysmenorrhea | 148 (97.4%) | 54 (94.3%) | 24 (100%) | 0.6382 |
| ≥ 5 VAS | 140 (92.1%) | 50 (87.7%) | 21 (87.5%) | 0.5419 |
| < 5 VAS | 8 (5.3%) | 4 (7%) | 3 (12.5%) | 0.3976 |
| Dyspareunia | 114 (75%) | 38 (66.7%) | 13 (54.2%) | 0.0828 |
| ≥ 5 VAS | 36 (23.7%) | 11 (19.3%) | 6 (25%) | 0.7667 |
| < 5 VAS | 78 (51.3%) | 27 (47.4%) | 7 (29.2%) | 0.1294 |
| Dyschezia | 91 (59.8%) | 38 (66.7%) | 18 (75%) | 0.2933 |
| ≥ 5 VAS | 25 (16.4%) | 12 (21.1%) | 13 (54.2%) | 0.0001* |
| < 5 VAS | 66 (43.4%) | 26 (45.6%) | 5 (20.8%) | 0.0887 |
| Dysuria | 68 (44.7%) | 19 (33.3%) | 10 (41.7%) | 0.3298 |
| ≥ 5 VAS | 8 (5.3%) | 6 (10.5%) | 2 (8.3%) | 0.3895 |
| < 5 VAS | 60 (39.5%) | 13 (22.8%) | 8 (33.3%) | 0.0780 |
| Hematochezia | 30 (19.7%) | 7 (12.3%) | 8 (33.3%) | 0.0883 |
| Hematuria | 26 (17.1%) | 10 (17.5%) | 4 (16.7%) | 0.9948 |
| CPP | 134 (88.2%) | 51 (89.5%) | 16 (66.7%) | 0.0126* |
| ≥ 5 VAS | 91 (59.8%) | 29 (50.9%) | 12 (50%) | 0.3971 |
| < 5 VAS | 43(28.3%) | 22 (38.6%) | 4 (16.7%) | 0.1185 |
| Monthly need for analgesia (days) mean ± SD | 5.75 ± 4.67 | 5.88 ± 4.44 | 5.18 ± 3.41 | 0.7605 |
| Nausea/vomiting | 81 (53.3%) | 33 (57.9%) | 13(54.2%) | 0.8370 |
| Diarrhea/obstipation/bloating | 140 (92.1%) | 52 (91.2%) | 22 (91.7%) | 0.9783 |
| AUB | 105 (69.1%) | 38 (66.7%) | 16 (66.7%) | 0.9315 |
| Infertility | 34 (22.4%) | 15 (26.3%) | 7 (29.2%) | 0.6908 |
* P value with significance level 0.05